Income (Loss) Per Common Share (Successor) - Anti Dilutive (Details) - shares |
1 Months Ended | 2 Months Ended | 9 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|---|
Oct. 31, 2019 |
Oct. 31, 2019 |
Dec. 31, 2019 |
Oct. 03, 2019 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||
| Financial Designation, Predecessor and Successor [Fixed List] | Successor | Successor | Successor | Predecessor | Successor | |
| Potential equivalent shares excluded | 2,355,008 | 2,410,000 | ||||
| Unvested Restricted Stock Units | ||||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||
| Potential equivalent shares excluded | 105,008 | 150,000 | ||||
| Restricted stock | ||||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||
| Potential equivalent shares excluded | 10,000 | |||||
| Warrants | ||||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||
| Potential equivalent shares excluded | 2,250,000 | 2,250,000 | ||||